{"id":"https://openalex.org/W4315618924","doi":"https://doi.org/10.1016/j.apsb.2023.01.007","title":"Supramolecular approaches for insulin stabilization without prolonged duration of action","display_name":"Supramolecular approaches for insulin stabilization without prolonged duration of action","alternate_titles":[],"publication_year":2023,"publication_date":"2023-01-11","ids":{"openalex":"https://openalex.org/W4315618924","doi":"https://doi.org/10.1016/j.apsb.2023.01.007","pmid":"https://pubmed.ncbi.nlm.nih.gov/37250160","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10213764"},"language":"en","primary_location":{"id":"doi:10.1016/j.apsb.2023.01.007","doi":"https://doi.org/10.1016/j.apsb.2023.01.007","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.apsb.2023.01.007","pdf_url":null,"source":{"id":"https://openalex.org/S2736993989","display_name":"Acta Pharmaceutica Sinica B","issn_l":"2211-3835","issn":["2211-3835","2211-3843"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-a","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharmaceutica Sinica B","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4315618924"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.apsb.2023.01.007","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005469350","display_name":"Rolande Meudom","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rolande Meudom","raw_affiliation_strings":["Department of Biochemistry, School of Medicine, University of Utah, Salt Lake City, UT 84112, USA","Division of Endocrinology and Diabetes, Department of Pediatrics, School of Medicine, Stanford University, Palo Alto, CA 94305, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry, School of Medicine, University of Utah, Salt Lake City, UT 84112, USA","institution_ids":["https://openalex.org/I223532165"]},{"raw_affiliation_string":"Division of Endocrinology and Diabetes, Department of Pediatrics, School of Medicine, Stanford University, Palo Alto, CA 94305, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020728100","display_name":"Yanxian Zhang","orcid":"https://orcid.org/0000-0001-6799-8491","observed_orcids":["https://orcid.org/0000-0001-6799-8491"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yanxian Zhang","raw_affiliation_strings":["Division of Endocrinology and Diabetes, Department of Pediatrics, School of Medicine, Stanford University, Palo Alto, CA 94305, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology and Diabetes, Department of Pediatrics, School of Medicine, Stanford University, Palo Alto, CA 94305, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048991045","display_name":"Michael A. VandenBerg","orcid":"https://orcid.org/0009-0006-8761-4700","observed_orcids":["https://orcid.org/0009-0006-8761-4700"]},"institutions":[{"id":"https://openalex.org/I107639228","display_name":"University of Notre Dame","ror":"https://ror.org/00mkhxb43","country_code":"US","type":"education","lineage":["https://openalex.org/I107639228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A. VandenBerg","raw_affiliation_strings":["Department of Chemical Engineering, University of Notre Dame, Notre Dame, IN 46556, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Engineering, University of Notre Dame, Notre Dame, IN 46556, USA","institution_ids":["https://openalex.org/I107639228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001976257","display_name":"Lei Zou","orcid":"https://orcid.org/0000-0001-8247-7184","observed_orcids":["https://orcid.org/0000-0001-8247-7184"]},"institutions":[{"id":"https://openalex.org/I107639228","display_name":"University of Notre Dame","ror":"https://ror.org/00mkhxb43","country_code":"US","type":"education","lineage":["https://openalex.org/I107639228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lei Zou","raw_affiliation_strings":["Department of Chemical Engineering, University of Notre Dame, Notre Dame, IN 46556, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Engineering, University of Notre Dame, Notre Dame, IN 46556, USA","institution_ids":["https://openalex.org/I107639228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068961244","display_name":"Yi Wolf Zhang","orcid":"https://orcid.org/0000-0001-8341-0539","observed_orcids":["https://orcid.org/0000-0001-8341-0539"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yi Wolf Zhang","raw_affiliation_strings":["Department of Biochemistry, School of Medicine, University of Utah, Salt Lake City, UT 84112, USA","Division of Endocrinology and Diabetes, Department of Pediatrics, School of Medicine, Stanford University, Palo Alto, CA 94305, USA"],"raw_orcid":"https://orcid.org/0000-0001-8341-0539","affiliations":[{"raw_affiliation_string":"Department of Biochemistry, School of Medicine, University of Utah, Salt Lake City, UT 84112, USA","institution_ids":["https://openalex.org/I223532165"]},{"raw_affiliation_string":"Division of Endocrinology and Diabetes, Department of Pediatrics, School of Medicine, Stanford University, Palo Alto, CA 94305, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034545287","display_name":"Matthew J. Webber","orcid":"https://orcid.org/0000-0003-3111-6228","observed_orcids":["https://orcid.org/0000-0003-3111-6228"]},"institutions":[{"id":"https://openalex.org/I107639228","display_name":"University of Notre Dame","ror":"https://ror.org/00mkhxb43","country_code":"US","type":"education","lineage":["https://openalex.org/I107639228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew J. Webber","raw_affiliation_strings":["Department of Chemical Engineering, University of Notre Dame, Notre Dame, IN 46556, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Engineering, University of Notre Dame, Notre Dame, IN 46556, USA","institution_ids":["https://openalex.org/I107639228"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065231427","display_name":"Danny Hung\u2010Chieh Chou","orcid":"https://orcid.org/0000-0001-9110-614X","observed_orcids":["https://orcid.org/0000-0001-9110-614X"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Danny Hung-Chieh Chou","raw_affiliation_strings":["Division of Endocrinology and Diabetes, Department of Pediatrics, School of Medicine, Stanford University, Palo Alto, CA 94305, USA"],"raw_orcid":"https://orcid.org/0000-0001-9110-614X","affiliations":[{"raw_affiliation_string":"Division of Endocrinology and Diabetes, Department of Pediatrics, School of Medicine, Stanford University, Palo Alto, CA 94305, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5065231427"],"corresponding_institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":{"value":0,"currency":"USD","value_usd":0},"fwci":1.4596,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.78463087,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"13","issue":"5","first_page":"2281","last_page":"2290"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10578","display_name":"Supramolecular Chemistry and Complexes","score":0.44359999895095825,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10578","display_name":"Supramolecular Chemistry and Complexes","score":0.44359999895095825,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11419","display_name":"Supramolecular Self-Assembly in Materials","score":0.09830000251531601,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.06430000066757202,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cucurbit-7-uril","display_name":"cucurbit[7]uril","score":0.9990000128746033},{"id":"https://openalex.org/keywords/polyethylene-glycol","display_name":"polyethylene glycol","score":0.7919999957084656},{"id":"https://openalex.org/keywords/insulin-aggregation","display_name":"insulin aggregation","score":0.8980000019073486},{"id":"https://openalex.org/keywords/duration-of-action","display_name":"duration of action","score":0.8730000257492065}],"concepts":[{"id":"https://openalex.org/C2779149719","wikidata":"https://www.wikidata.org/wiki/Q682252","display_name":"PEGylation","level":3,"score":0.8772499561309814},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.8241503238677979},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6654638051986694},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6440346837043762},{"id":"https://openalex.org/C2776964284","wikidata":"https://www.wikidata.org/wiki/Q410083","display_name":"Polyethylene glycol","level":2,"score":0.6404592990875244},{"id":"https://openalex.org/C54400483","wikidata":"https://www.wikidata.org/wiki/Q1793202","display_name":"PEG ratio","level":2,"score":0.5988782048225403},{"id":"https://openalex.org/C93275456","wikidata":"https://www.wikidata.org/wiki/Q756449","display_name":"Supramolecular chemistry","level":3,"score":0.5278477668762207},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37240201234817505},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3313726484775543},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3010782301425934},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23166310787200928},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.14579889178276062},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.12157109379768372},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10585743188858032},{"id":"https://openalex.org/C115624301","wikidata":"https://www.wikidata.org/wiki/Q895901","display_name":"Crystal structure","level":2,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/j.apsb.2023.01.007","doi":"https://doi.org/10.1016/j.apsb.2023.01.007","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.apsb.2023.01.007","pdf_url":null,"source":{"id":"https://openalex.org/S2736993989","display_name":"Acta Pharmaceutica Sinica B","issn_l":"2211-3835","issn":["2211-3835","2211-3843"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-a","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharmaceutica Sinica B","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10213764","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10213764","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10213764/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharm Sin B","raw_type":"Text"},{"id":"pmid:37250160","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37250160","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta pharmaceutica Sinica. B","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:520b9d2dac8d4cbdaad4bf1c1ca309a0","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/520b9d2dac8d4cbdaad4bf1c1ca309a0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Acta Pharmaceutica Sinica B, Vol 13, Iss 5, Pp 2281-2290 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.apsb.2023.01.007","doi":"https://doi.org/10.1016/j.apsb.2023.01.007","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.apsb.2023.01.007","pdf_url":null,"source":{"id":"https://openalex.org/S2736993989","display_name":"Acta Pharmaceutica Sinica B","issn_l":"2211-3835","issn":["2211-3835","2211-3843"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-a","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharmaceutica Sinica B","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1882998668","display_name":null,"funder_award_id":"5\u2010CDA\u20102020\u2010947\u2010A\u2010N","funder_id":"https://openalex.org/F4320310820","funder_display_name":"Juvenile Diabetes Research Foundation United States of America"},{"id":"https://openalex.org/G207208654","display_name":"DEVELOPMENT OF CONCENTRATED, STABLE ULTRA FAST-ACTING INSULIN FORMULATION","funder_award_id":"R01DK120430","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G2073401597","display_name":"Development of long-acting glucose-responsive insulin formulations","funder_award_id":"R01DK121336","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G8942089002","display_name":null,"funder_award_id":"DK121336","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"}],"funders":[{"id":"https://openalex.org/F4320310820","display_name":"Juvenile Diabetes Research Foundation United States of America","ror":"https://ror.org/00vqxjy61"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4315618924.pdf","grobid_xml":"https://content.openalex.org/works/W4315618924.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W15436629","https://openalex.org/W55058915","https://openalex.org/W1524122182","https://openalex.org/W1963122402","https://openalex.org/W1983344857","https://openalex.org/W1983792486","https://openalex.org/W1988089792","https://openalex.org/W2007869738","https://openalex.org/W2030136986","https://openalex.org/W2030241173","https://openalex.org/W2052636578","https://openalex.org/W2074941927","https://openalex.org/W2077534391","https://openalex.org/W2100974520","https://openalex.org/W2101001804","https://openalex.org/W2102361084","https://openalex.org/W2112366494","https://openalex.org/W2119304571","https://openalex.org/W2133683196","https://openalex.org/W2301521579","https://openalex.org/W2559177805","https://openalex.org/W2568910234","https://openalex.org/W2606900487","https://openalex.org/W2767718126","https://openalex.org/W2805748529","https://openalex.org/W2987294264","https://openalex.org/W2991794854","https://openalex.org/W3183862157","https://openalex.org/W3216165129","https://openalex.org/W6669792316"],"related_works":["https://openalex.org/W2996387778","https://openalex.org/W3183862157","https://openalex.org/W2053362850","https://openalex.org/W3023222482","https://openalex.org/W1684620173","https://openalex.org/W2084306327","https://openalex.org/W2559177805","https://openalex.org/W4392362349","https://openalex.org/W2403413485","https://openalex.org/W1988092478"],"abstract_inverted_index":{"Aggregation":[0],"represents":[1],"a":[2,69,159,171,203],"significant":[3],"challenge":[4],"for":[5,57],"the":[6,50,54,77,108,114,119,164,186,199],"long-term":[7],"formulation":[8,137],"stability":[9,138,196],"of":[10,16,20,42,73,110,118,162,174,188,191,211],"insulin":[11,17,31,59,81,96,122,166,179,192],"therapeutics.":[12],"The":[13],"supramolecular":[14,85,189],"PEGylation":[15,86,190],"with":[18,129,168,181],"conjugates":[19],"cucurbit[7]uril":[21],"and":[22,61,106,149],"polyethylene":[23],"glycol":[24],"(CB[7]\u2012PEG)":[25],"has":[26],"been":[27],"shown":[28],"to":[29,84,98,126,154,177,193],"stabilize":[30],"formulations":[32],"by":[33,112],"reducing":[34,198],"aggregation":[35],"propensity.":[36],"Yet":[37],"prolonged":[38],"in":[39,49,75,147,150,158,208],"vivo":[40,151,209],"duration":[41,109,173,210],"action,":[43],"arising":[44,201],"from":[45,202],"sustained":[46],"complex":[47],"formation":[48],"subcutaneous":[51,115,204],"depot,":[52],"limits":[53],"application":[55,187],"scope":[56],"meal-time":[58],"uses":[60],"could":[62],"increase":[63],"hypoglycemic":[64],"risk":[65],"several":[66],"hours":[67],"after":[68],"meal.":[70],"Supramolecular":[71],"affinity":[72,102],"CB[7]":[74,100],"binding":[76],"B1-Phe":[78],"residue":[79],"on":[80],"is":[82],"central":[83],"using":[87],"this":[88],"approach.":[89],"Accordingly,":[90,142],"here":[91],"we":[92],"synthesized":[93],"N-terminal":[94,143],"acid-modified":[95,165],"analogs":[97,123,145],"reduce":[99,107],"interaction":[101,128],"at":[103,131,139],"physiological":[104,132],"pH":[105,133],"action":[111,175],"decreasing":[113],"depot":[116,205],"effect":[117,206],"formulation.":[120],"These":[121],"show":[124],"weak":[125],"no":[127],"CB[7]\u2012PEG":[130,169],"but":[134],"demonstrate":[135],"high":[136],"reduced":[140,172],"pH.":[141],"modified":[144],"have":[146],"vitro":[148],"bioactivity":[152],"comparable":[153],"native":[155,178],"insulin.":[156],"Furthermore,":[157],"rat":[160],"model":[161],"diabetes,":[163],"formulated":[167,180],"offers":[170],"compared":[176],"CB[7]\u2012PEG.":[182],"This":[183],"work":[184],"extends":[185],"achieve":[194],"enhanced":[195],"while":[197],"risks":[200],"prolonging":[207],"action.":[212]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4315618924","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2023-01-12T00:00:00"}
